MLTX

MoonLake Immunotherapeutics

Insider Trades

NameValueActionPriceCurrent Price
Bodenstedt MatthiasChief Financial Officer
$273k13.7k shares
SellMay 11, 2026
$20.02
--
Bodenstedt MatthiasChief Financial Officer
$47k2.4k shares
SellApr 14, 2026
$19.56
--
Santos da Silva JorgeDirector, Officer: Chief Executive Officer
$946k51.9k shares
SellApr 13, 2026
$18.23
--
Santos da Silva JorgeDirector, Officer: Chief Executive Officer
$1.8M98.1k shares
SellApr 10, 2026
$18.41
--
Bodenstedt MatthiasChief Financial Officer
$38k1.9k shares
SellApr 10, 2026
$19.51
--
Bodenstedt MatthiasChief Financial Officer
$1.6M85.9k shares
SellApr 9, 2026
$18.94
--

News

fool.comMoonLake Immunotherapeutics CFO Trims His Stake. Should Investors Be Concerned?fool.comJun 4benzinga.comFDA Aligns With MoonLake On Lead Drug Submission Plans, Stock Soarsbenzinga.comMay 11investors.comMoonLake Clears A Key Regulatory Hurdle, And Shares Rocketinvestors.comMay 11globenewswire.comMoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Resultsglobenewswire.comMay 10fool.comThe CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?fool.comApr 18